RxDoctor Payments Data

Andrew Simon, MD

Orthopaedic Surgery · Camden, NJNPI 1215384656

Payments from drug & device makers

$1,100in general payments, 2019–2025

Across 12 payments — averaging $91.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$381
  • Polynovo North America LLC$198
  • Axogen$136
  • Skeletal Dynamics Inc$119
  • Carbofix Orthopedics Inc$114
  • Integra Lifesciences Corporation$77
  • plus $75 from 1 others

What the payments were for

  • Food & beverage$1,100100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker6$381
Polynovo North America LLC1$198
Axogen1$136
Skeletal Dynamics Inc1$119
Carbofix Orthopedics Inc1$114
Integra Lifesciences Corporation1$77
Bonalive Inc1$75

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,100 in reported general payments places this provider in the 35th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$47,158
Medicare patients
139
Services billed
435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl13$725

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →